Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: The Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey

HIV Medicine

Volumn 16, Issue 4, 2015, Pages 230-239

  Rosenthal, E ^a,b,l   Roussillon, C ^c,d   Salmon Ceron D ^e   Georget, A ^c   Henard S ^f   Huleux, T ^g   Gueit, I ^h,l   Mortier, E ⁱ   Costagliola, D ^c,j   Morlat, P ^d,k,l   Chene G ^c   Cacoub, P ^j,l,l,m,n   Pautard Huchemble B ^l   Schmit, J L ^l   Bonnefoy, M ^l   Bru, J P ^l   Gaillat, J ^l   Lerousseau, L ^l   Dubois, D ^l   Azzedine, A ^l   De La Blanchardiere A ^l   Lepeu, G ^l   Faller, J P ^l   Balvay, P ^l   Barale, F ^l   Estavoyer, J M ^l   Vuitton, D ^l   Bentata, M ^l   Cohen, P ^l   Guillevin, L ^l   Jarrousse, B ^l   Padrazzi, B ^l   Beylot, J ^l   Bernard, N ^l   Constans, J ^l   Loury, I ^l   Moreau, F ^l   Ragnaud, J M ^l   Viaud, J F ^l   Lacoste, D ^l   Baglin, A ^l   Dorra, M ^l   Dupont, C ^l,l   Hanslik, T ^l   Rouveix, E ^l   Granier, P ^l   Cenac A ^l   Bazin, C ^l   Hazera, P ^l   Verdon, R ^l   Schmidt, J ^l   Rogeaux, O ^l   Menalba, C ^l   Boue F ^l   Fior, R ^l   Galanaud, P ^l   Pik, J J ^l   Beytout, J ^l   Laurichesse, H ^l   Ruivard, M ^l   Laplatte, G ^l   Audoy, B ^l   Plaisance, N ^l   Bouterra, C ^l   Laylotte, G ^l   Delarocque, E ^l   Vinceneux, P ^l   Lesprit, P ^l   Schaeffer, A ^l   Grappin, M ^l   Greuzard, M C ^l   Loudes Chauvin, M C ^l   Portier, H ^l   Vinceneux, M ^l   Guillaumie, J ^l   Dournovo, P ^l   De Truchis, B ^l   Perronne, C ^l   Bouchard, O ^l   Micoud, M ^l   Morand, P ^l   Boucher, J ^l   Chambourlier, P ^l   Renou, C ^l   Arvin Berod, C ^l   Poubeau, P ^l   Perre, P ^l   Hachulla, E ^l   Devulder, B ^l   Hatron, P Y ^l   Loustaud Ratti, V ^l   Berthou, J D ^l   Baborier, D ^l   Constant, E ^l   Dufay, E ^l   Peyramond, D ^l   Tremolieres F ^l   Bourgeade, A ^l   Durand, J M ^l   Gastaut, J A ^l   Gallais, H ^l   Moreau, J ^l   Perret, J L ^l   Poizot Martin, I ^l   Soubeyrand, J ^l   Meissonnier, P ^l   Hayek, R ^l   Constant, C ^l   Raabe, J J ^l   Wang, A ^l   Astruc, J ^l   Blanc, F ^l   Perney, P ^l   Vandome A ^l   Bautoille, D ^l   Guerbois, C ^l   Loyau, C ^l   Raffi, F ^l   Villers, D ^l   Burty, C ^l   Canton, P ^l   de Korwin, J D ^l   Thibaut, G ^l   Wahl, D ^l   Breaud, S ^l   Durant, J ^l   Fuzibet, J G ^l   Joulie A ^l   Naqvi, A ^l   Pradier, C ^l   Roger, P M ^l   Raffanel, C ^l   Amoura, Z ^l   Aumaitre, H ^l   Bani Sadr, F ^l   Bergmann, J F ^l   Bissuel, F ^l   Boissonnas, A ^l   Bouvet, E ^l   Bricaire, F ^l   Cabane, J ^l   Cabie A ^l   Caquet, R ^l   Carbon, C ^l   Caulin, C ^l   Chemlal, K ^l   Coulaud, J P ^l   de Beaumont, T ^l   Devars du Mayne, F ^l   Durand, B ^l   Farge, D ^l   Gaudebout, C ^l   Gilquin, J ^l   Goujard, C ^l   Hausfater, P ^l   Katlama, C ^l   Karmochkine, M ^l   Krainik, F ^l   Le Bras, P ^l   Le Moing, V ^l   Leport, C ^l   Modai J ^l   Molina, J M ^l   Pialoux, G ^l   Piette, J C ^l   Poinsignon, Y ^l   Quertainmont, Y ^l   Raguin, G ^l   Rozenbaum, W ^l   Sicard, D ^l   Simon, J ^l   Vachon, F ^l   Valleron, A J ^l   Vilde J ^l   Arsac, P ^l   Calamy, G ^l   Mille, C ^l   Mercie, P ^l   Pellegrin, J L ^l   Becq Giraudon B B , ^l   Breux, J P ^l   Le Moal, G ^l   Michelet, C ^l   Cartier, F ^l   Beguinot, I ^l   Remy G ^l   Borsa Lebas, F ^l   Caron, F ^l   Wemeau, J ^l   Hascouet, C ^l   Le Cam, B ^l   Khuong, M A ^l   Mechali, D ^l   Roblin, X ^l   Defontaine, C ^l   Lucht, F ^l   Fegueux S ^l   Veyssier Belot, C ^l   Ouzan, D ^l   Kitschke, B ^l   Clement Bertoldo C ^l   Gonzales, G ^l   Fischer, P ^l   Lang, J M ^l   Rey, D ^l   Ruellan, A ^l   Schlienger, J L ^l   Zucman, D ^l   Bletry O ^l   Romand, P ^l   Alric, L ^l   Cuzin, L ^l   Duffaut, M ^l   Ajana, F ^l   Mouton, Y ^l   Yazdanpanah, Y ^l   Borderon, J C ^l   Choutet, P ^l   Guimard, Y ^l   Patey, O ^l   more..

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e Institut Cochin   (France)

^f CHU NANCY BRABOIS   (France)

^g CENTRE HOSPITALIER DE TOURCOING   (France)

^h HÔPITAL CHARLES NICOLLE   (France)

ⁱ HÔPITAL LOUIS MOURIER   (France)

^j SORBONNE UNIVERSITÉ   (France)

^k HÔPITAL SAINT ANDRÉ   (France)

^l Sorbonne Université   (France)

^m CNRS   (France)

ⁿ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

more..

Author keywords

Cirrhosis; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; HIV; Mortality

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALCOHOL CONSUMPTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC LIVER DISEASE; CROSS-SECTIONAL STUDY; DATA BASE; DEATH; FEMALE; FRANCE; HEALTH SURVEY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PRIORITY JOURNAL; VIRUS LOAD; ALCOHOL LIVER CIRRHOSIS; CAUSE OF DEATH; CHRONIC HEPATITIS C; COMPARATIVE STUDY; COMPLICATION; DRINKING BEHAVIOR; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LIVER TUMOR; MIDDLE AGED; PROSPECTIVE STUDY; TRENDS;

ADULT; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84924766321     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/hiv.12204     Document Type: Article

References (51)

1. Puoti M, Spinetti A, Ghezzi A etal. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquired Immune Defic Syndr 2000; 24: 211-217.
2. Martin-Carbonero L, Soriano V, Valencia ME, Lopez M, Gonzalez-Lahoz J. Impact of chronic viral hepatitis on hospital admission and mortality in HIV-infected patients. AIDS Res Hum Retroviruses 2001; 17: 1467-1471.
3. Soriano V, Garcia-Samaniego J, Valencia E, Rodriguez-Rosado R, Munoz F, Gonzalez-Lahoz J. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur J Epidemiol 1999; 15: 1-4.
4. Bica I, McGovern B, Dhar L etal. Increasing mortality due to end-stage liver disease in patients with HIV infection. Clin Infect Dis 2001; 32: 492-497.
5. Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G. Mortality among HIV-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis virus C in French departments of Internal Medicine/Infectious Diseases in 1995 and 1997. Clin Infect Dis 2001; 32: 1207-1214.
6. Rosenthal E, Poirée M, Pradier C etal. Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study). AIDS 2003; 17: 1803-1809.
7. Rosenthal E, Pialoux G, Bernard N etal. Liver-related mortality in human immunodeficiency virus-infected patients between 1995 and 2003 in the French GERMIVIC Joint Study Group Network (MORTAVIC 2003 Study). J Viral Hepat 2007; 14: 183-188.
8. Rosenthal E, Salmon-Céron D, Lewden C etal. Liver-related deaths in HIV-infected patients between 1995 and 2005 in the French GERMIVIC Joint Study Group Network (Mortavic 2005 Study in collaboration with the Mortalite' 2005 survey, ANRS EN19). HIV Med 2009; 10: 282-289.
9. Chung R, Andersen J, Volberding P etal. Peginterferon alfa-2a plus ribavirin vs interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV co-infected persons. N Engl J Med 2004; 351: 451-459.
10. Carrat F, Bani-Sadr F, Pol S etal. Pegylated-interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV infected patients: a randomized controlled trial. JAMA 2004; 292: 2839-2848.
11. Cacoub P, Rosenthal E, Halfon P, Sene D, Perronne C, Pol S. Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life. J Viral Hepat 2006; 13: 678-682.
12. Cacoub P, Halfon P, Rosenthal E etal. Treatment of hepatitis C virus in human immunodeficiency virus infected patients in the real life: modifications in two large surveys between 2004 and 2006. J Hepatol 2008; 48: 35-42.
13. Berenguer J, Rodriguez E, Miralles P etal. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis 2012; 55: 728-736.
14. Lewden C, May T, Rosenthal E etal. Changes in causes of death among adults infected by HIV between 2000 and 2005: the 'Mortalité 2000 and 2005' surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008; 48: 590-598.
15. Lewden C, Salmon D, Morlat P etal. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34: 121-130.
16. Anonymous. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729-730.
17. International Classification of Diseases, Tenth revision edn. Geneva, World Health Organization, 1993.
18. Bernillon P, Lievre L, Pillonel J, Laporte A, Costagliola D. Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993. The Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine. Int J Epidemiol 2000; 29: 168-174.
19. Morlat P, Roussillon C, Henard S etal. Causes of death among HIV-infected patients in France in 2010 (ANRS EN20 Mortalité 2010 study) - trends since 2000. AIDS 2014; 28: 1181-1191.
20. Salmon-Ceron D, Lewden C, Morlat P etal. Liver disease as a major cause of death in HIV-infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol 2005; 42: 799-805.
21. Camino X, Iribarren JA, Arrizabalga J, Rodriguez F, Von Wichmann AM. Causes of mortality among patients infected with the human immunodeficiency virus in the era of highly active antiretroviral therapy. Enferm Infecc Microbiol Clin 2001; 19: 85-86.
22. Palella FJ, Baker RK, Moorman AC etal. Mortality in the highly active antiretroviral therapy era. Changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006; 43: 27-34.
23. Weber R, Sabin CA, Friis-Møller N etal. Liver-related deaths in persons infected with the human immunodeficiency virus. The D:A:D study. Arch Intern Med 2006; 166: 1632-1641.
24. Weber R, Ruppik M, Rickenbach M etal. Decreasing mortality and changing patterns of causes of deaths in the Swiss HIV Cohort Study. HIV Med 2013; 14: 195-207.
25. Torriani FJ, Rodriguez-Torres M, Rockstroh J etal. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C infection in HIV-infected patients. N Engl J Med 2004; 351: 438-450.
26. Fleming CA, Craven DE, Thornton D, Tumilty S, Nunes D. Hepatitis C virus and human immunodeficiency virus coinfection in a urban population: low eligibility for interferon treatment. Clin Infect Dis 2003; 36: 97-100.
27. Fleming CA, Tumilty S, Murray JE, Nunes D. Challenges in the patients coinfected with HIV and hepatitis C virus: need for teem care. Clin Infect Dis 2005; 40 (Suppl 5): S349-S354.
28. Cacoub P, Halfon P, Rosenthal E etal. Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: modifications in three consecutive large surveys between 2004 and 2009. J Hepatol 2010; 53: 230-237.
29. Puoti M, Bruno R, Soriano V etal. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome. AIDS 2004; 18: 2285-2293.
30. Salmon-Ceron D, Rosenthal E, Lewden C etal. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French national Mortalité 2005 study. J Hepatol 2009; 50: 736-745.
31. Benhamou Y, Bochet M, Di Martino V etal. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 1999; 30: 1054-1058.
32. Bräu N, Fox RK, Xiao P etal. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol 2007; 47: 447-450.
33. Bourcier V, Winnock M, Ait Ahmed M etal. Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir). Clin Res Hepatol Gastroenterol 2012; 36: 214-221.
34. Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El-Serag HB. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma un US veterans with hepatitis C. Am J Gastroenterol 2005; 100: 56-63.
35. Degos F, Tural C. Hepatocellular carcinoma in human immunodeficiency virus (HIV)-infected patients: is it really different, and if so, why? J Hepatol 2007; 47: 447-450.
36. Salmon D, Bani-Sadr F, Loko MA etal. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH. J Hepatol 2012; 56: 862-868.
37. Hunt PW. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 2012; 9: 139-147.
38. Guiguet M, Boué F, Cadranel J etal. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol 2009; 10: 1152-1159.
39. Merchante N, Merino E, López-Aldeguer J etal. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain. Clin Infect Dis 2013; 56: 143-150.
40. Carton JA, Collazos J, de la Fuente B, Asensi V. Course of liver fibrosis in HIV-hepatitis C virus-coinfected patients depending on the response to hepatitis C therapy. AIDS Res Hum Retroviruses 2013; 29: 215-222.
41. Morgan TR, Ghany MG, Kim HY etal. Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology 2010; 52: 833-844.
42. van der Helm J, Geskus R, Sabin C etal. Effect of HCV infection on cause-specific mortality following HIV seroconversion before and after 1997. Gastroenterology 2013; 144: 751-760.
43. Lekas HM, Siegel K, Leder J. Challenges facing providers caring for HIV/HVC-coinfected patients. Qual Health Res 2012; 22: 54-66. doi: 10.1177/1049732311418248.
44. Pol S, Fontaine H, Carnot F etal. Predictive factors for cirrhosis development in parenterally-acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J Hepatol 1998; 29: 12-19.
45. Wiley TE, McCarthy M, Breidi L, McCarthy M, Layden TJ. Impact of alcohol on the histological progression of hepatitis C infection. Hepatology 1998; 28: 805-809.
46. Tsui JI, Saitz R, Cheng DM etal. Awareness of hepatitis C diagnosis is associated with less alcohol use among persons co-infected with HIV. J Gen Intern Med 2007; 22: 822-825.
47. Nalpas B, Martin S, Fontaine H, Fabbro-Perret P, Bréchot C, Pol S. Impact of medical recommendations on alcohol consumption in HCV positive patients. J Hepatol 2001; 35: 312-313.
48. Larsen C, Pialoux G, Salmon D etal. Prévalence des co-infections par les virus des hépatites B et C dans la population VIH+, France, juin 2004. BEH 2005; 23: 109-112.
49. Piroth L, Pol S, Lacombe K etal. Management and treatment of chronic hepatitis B virus infection in HIV positive and negative patients: the EPIB 2008 study. J Hepatol 2010; 53: 1006-1012.
50. Qurishi N, Kreuzberg C, Lüchters G etal. Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. Lancet 2003; 362: 1708-1713.
51. Kramer JR, Giordano TP, El-Seraq HB. Effect of human immunodeficiency virus and antiretrovirals on outcomes of hepatitis C: a systematic review from an epidemiologic perspective. Clin Gastroenterol Hepatol 2007; 5: 1321-1328.